<html><head><title>Cancer</title></head><body>
<h2>Papers tagged with: Cancer</h2>
<ul>
<li>Prevalence and Correlates of Cervical Cancer Prevention Knowledge Among High School Students in Ghana</li>
<li>Improving self-management of cancer risk factors, underscreening for cancer and depression among general practice patients: Study protocol of a randomised controlled trial</li>
<li>Convergent and criterion validity of PROMIS anxiety measures relative to six legacy measures and a structured diagnostic interview for anxiety in cancer patients</li>
<li>Chemoradiotherapy with concurrent durvalumab for the palliative treatment of oligometastatic oesophageal and gastrooesophageal carcinoma with dysphagia: a single arm phase II clinical trial (PALEO, sponsored by the Australasian Gastro-Intestinal Trials Group)</li>
<li>Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease</li>
<li>Perineural invasion by prostate adenocarcinoma in needle biopsies predicts bone metastasis: Ten year data from the TROG 03.04 RADAR Trial</li>
<li>Cross-Sectional Data That Explore the Relationship Between Outpatients' Quality of Life and Preferences for Quality Improvement in Oncology Settings</li>
<li>Non-pharmacological approaches to procedural anxiety reduction for patients undergoing radiotherapy for cancer: Systematic review protocol</li>
<li>A systematic review of nonpharmacological interventions to reduce procedural anxiety among patients undergoing radiation therapy for cancer</li>
<li>Cross-sectional data that explore the relationship between outpatients{'} quality of life and preferences for quality improvement in oncology settings</li>
<li>The receptor tyrosine kinase trka is increased and targetable in HER2-positive breast cancer</li>
<li>Improving self-management of cancer risk factors, underscreening for cancer and depression among general practice patients: study protocol of a randomised controlled trial</li>
<li>CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial</li>
<li>TROG 18.01 phase III randomised clinical trial of the Novel Integration of New prostate radiation schedules with adJuvant Androgen deprivation: NINJA study protocol</li>
<li>Smoking, drinking, and depression: comorbidity in head and neck cancer patients undergoing radiotherapy</li>
<li>Bladder carcinoma in situ (CIS) in Australia: A rising incidence for an under-reported malignancy</li>
<li>Assessing the impact of magnetic resonance treatment simulation (MRSIM) on target volume delineation and dose to organs at risk for oropharyngeal radiotherapy</li>
<li>Bladder carcinomain situ({CIS}) in Australia: a rising incidence for an under-reported malignancy</li>
<li>DPYD genotype-guided dose personalisation for fluoropyrimidine-based chemotherapy prescribing in solid organ cancer patients in Australia: GeneScreen 5-FU study protocol</li>
<li>Current patterns of care in low-risk thyroid cancer?A national cross-sectional survey of Australian thyroid clinicians</li>
</ul>
</body></html>
